Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma

Lazar Vujanovic, Pedro Torres-Saavedra, Fei Tu, Ravindra Uppaluri, Min Yao, Josephine Chen, Richard Jordan, Jessica L. Geiger, Srinivas Jujjavarapu, Arnab Chakravarti, Minh Phan, Farzan Siddiqui, Aditi Kulkarni, Pragati Upadhyay, Brian Robert Isett, Gabriel L. Sica, Carly Reeder, Riyue Bao, Jie Chen, Marion Joy, Tanner Freeman, Jonathan Harris, Quynh-Thu Le, Julie E. Bauman, Robert L. Ferris

Open source

DOI: 10.1158/1078-0432.ccr-25-4796
Published: 2026-06-25
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-4796,
  title = {Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma},
  author = {Lazar Vujanovic and Pedro Torres-Saavedra and Fei Tu and Ravindra Uppaluri and Min Yao and Josephine Chen and Richard Jordan and Jessica L. Geiger and Srinivas Jujjavarapu and Arnab Chakravarti and Minh Phan and Farzan Siddiqui and Aditi Kulkarni and Pragati Upadhyay and Brian Robert Isett and Gabriel L. Sica and Carly Reeder and Riyue Bao and Jie Chen and Marion Joy and Tanner Freeman and Jonathan Harris and Quynh-Thu Le and Julie E. Bauman and Robert L. Ferris},
  year = {2026},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-4796},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-4796}
}

RIS

TY  - JOUR
TI  - Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma
AU  - Lazar Vujanovic
AU  - Pedro Torres-Saavedra
AU  - Fei Tu
AU  - Ravindra Uppaluri
AU  - Min Yao
AU  - Josephine Chen
AU  - Richard Jordan
AU  - Jessica L. Geiger
AU  - Srinivas Jujjavarapu
AU  - Arnab Chakravarti
AU  - Minh Phan
AU  - Farzan Siddiqui
AU  - Aditi Kulkarni
AU  - Pragati Upadhyay
AU  - Brian Robert Isett
AU  - Gabriel L. Sica
AU  - Carly Reeder
AU  - Riyue Bao
AU  - Jie Chen
AU  - Marion Joy
AU  - Tanner Freeman
AU  - Jonathan Harris
AU  - Quynh-Thu Le
AU  - Julie E. Bauman
AU  - Robert L. Ferris
PY  - 2026
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-25-4796
UR  - https://doi.org/10.1158/1078-0432.ccr-25-4796
ER  -

APA

Vujanovic, L., Torres-Saavedra, P., Tu, F., Uppaluri, R., Yao, M., Chen, J., Jordan, R., Geiger, J. L., Jujjavarapu, S., Chakravarti, A., Phan, M., Siddiqui, F., Kulkarni, A., Upadhyay, P., Isett, B. R., Sica, G. L., Reeder, C., Bao, R., Chen, J., Joy, M., Freeman, T., Harris, J., Le, Q., Bauman, J. E., & Ferris, R. L. (2026). Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-4796

Source records

crossref · retrieved 2026-09-26T04:29:30.715Z